A validated stability indicating ultra performance liquid chromatographic method for determination of impurities in Esomeprazole magnesium gastro resistant tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 57, Issue 1, 2012, Pages 109-114

  Nalwade, Santaji Uttam ^a,b   Reddy, Vangala Ranga ^a   Rao, Dantu Durga ^a   Morisetti, Nagendra kumar ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Development; Esomeprazole magnesium; Impurities; UPLC; Validation

Indexed keywords

ACID; BASE; ESOMEPRAZOLE;

ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IMPURITY; DRUG STABILITY; FLOW RATE; HYDROLYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; TABLET; THERMAL ANALYSIS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; OMEPRAZOLE; SPECTROPHOTOMETRY, INFRARED; TABLETS;

EID: 80054011661     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.08.025     Document Type: Article

References (14)

1. Tonini M., Vigneri S., Savarino V., Scarpignato C. Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor. Dig. Liver Dis. 2001, 33:600-606.
2. Kale-Pradhan P.B., Landry H.K., Sypula W.T. Esomeprazole for acid peptic disorders. Ann. Pharmacother. 2002, 36:655-663.
3. Luga C., Bojita M., Hudrea F., Miron M. Quantitative determination of omeprazole in bulk and in pharmaceuticals. Farmacia (Bucharest) 1997, 45:43-51.
4. Salama F., El-Abasawy N., Abdel Razeq S.A., Ismail M.M.F., Fouad M.M. Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates. J. Pharm. Biomed. Anal. 2003, 33:411-421.
5. Wahbi A-A.M., Abdel-Razak O., Gazy A.A., Mahgoub H., Moneeb M.S. Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations. J. Pharm. Biomed. Anal. 2002, 30:1133-1142.
6. Karljikovic-Rajic K., Novovic D., Marinkovic V., Agbaba D. First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities. J. Pharm. Biomed. Anal. 2003, 32:1019-1027.
7. Castro D., Moreno M.A., Torrado S., Lastres J.L. Comparison of derivative spectrophotometric and liquid chromatographic methods for the determination of omeprazole in aqueous solutions during stability studies. J. Pharm. Biomed. Anal. 1999, 21:291-298.
8. Ruiz M.A., Reyes I., Parera A., Gallardo V. Determination of the stability of omeprazole by means of differential scanning calorimetry. J. Therm. Anal. Calorim. 1998, 51:29-35.
9. Ekpe A., Jacobsen T. Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography. Drug Dev. Ind. Pharm. 1999, 25:1057-1065.
10. Armagan Onal, Aysel Oztunc Development and validation of high performance liquid chromatographic method for the determination of esomeprazole in tablets. J. Food Drug Anal. 2006, 14:12-18.
11. United States Pharmacopeia and National Formulary (USP 27/NF 22) 2004, The US Pharmacopeial Convention, Rockville, MD, USA, pp. 1358-1359.
12. British Pharmacopeia 2004, vol. II. Her Majesty's Stationery Office, London, UK, pp. 1428-1429.
13. ICH Q2 (R1) Validation of Analytical Procedures: Text and Methodology 2005.
14. ICH Q1A (R2) Stability Testing of New Drug Substances and Products 2000.